Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The U.S. government's principal agency for cancer research
For Childhood Cancer Awareness Month, the National Cancer Institute’s Director Dr. Ned Sharpless reflects on childhood cancer progress.
Learn how to identify sources of misinformation about cancer—and how to find truly reliable information.
Physical activity may help people avoid “brain fog” while undergoing chemotherapy for breast cancer.
Adolescents and young adults are using mobile devices to document the impact of cancer and its treatment on their quality of life.
Some kids with this fast-growing brain cancer can safely get less radiation without limiting their long-term survival.
A cancer therapy that delivers radiation directly to cancer cells may represent the newest advance in the treatment of prostate cancer.
National Cancer Institute-supported studies are testing ways to pick out people whose diabetes might be a sign of pancreatic cancer.
A combination of two immunotherapy drugs may be more effective than the current standard treatment, chemotherapy.
People diagnosed with advanced melanoma may soon have a new treatment option that combines two immunotherapy drugs.
A study found that people over 75 who were screened by colonsocopy or sigmoidoscopy had a reduced risk of death from colorectal cancer.
A combination of two targeted therapies led to long-lasting remission in a small study of patients with hairy cell leukemia.
More radical hysterectomies in women with early-stage cervical cancer are being performed by “open” surgery.
Researchers appear to have uncovered a previously unknown check on dividing cells.
DNA sequencing technology helps explore the effects of radiation from the Chernobyl nuclear disaster on human health.
The new findings are an important first step in moving toward using even less radiation to treat high-risk pediatric Hodgkin lymphoma.
Text messaging and mailing people free, at-home test kits can help boost the number of people who get screened for colorectal cancer.
The test could help patients with ER-positive breast cancer avoid months of ineffective treatment during which their disease may progress.
Efforts to reach patients during the COVID-19 pandemic has led to both setbacks and new innovations in cancer screening.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.